quinazolines has been researched along with novobiocin in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bose, A; D'Andrea, AD; Grochala, C; Kozono, D; Lazaro, JB; Liu, J; McQueen, K; Nguyen, H; Parmar, K; Patterson-Fortin, J; Shapiro, GI; Tsai, WC; Zhou, J | 1 |
1 other study(ies) available for quinazolines and novobiocin
| Article | Year |
|---|---|
Targeting DNA Repair with Combined Inhibition of NHEJ and MMEJ Induces Synthetic Lethality in TP53-Mutant Cancers.
Topics: DNA; DNA End-Joining Repair; DNA Repair; DNA-Activated Protein Kinase; DNA-Directed DNA Polymerase; Humans; Neoplasms; Novobiocin; Pyridazines; Quinazolines; Synthetic Lethal Mutations; Tumor Suppressor Protein p53 | 2022 |